![](/img/cover-not-exists.png)
Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01
Wilkinson, Alexander, Lattmann, Eric, Roces, Carla B., Pedersen, Gabriel, Christensen, Dennis, Perrie, YvonneLanguage:
english
Journal:
Journal of Controlled Release
DOI:
10.1016/j.jconrel.2018.10.002
Date:
October, 2018
File:
PDF, 934 KB
english, 2018